No Data
No Data
No Data
No Data
No Data
Panbela Therapeutics Announces Delay of Expected Data From Pancreatic Cancer Treatment Trial
Seeking AlphaApr 22 09:18 ET
Panbela Therapeutics Updates ASPIRE Trial Timeline
TipRanksApr 22 08:12 ET
Express News | Panbela Therapeutics Inc: Interim Data Analysis for Aspire Trial Pushed to Q1 2025
Moomoo 24/7Apr 22 08:04 ET
Panbela Applies to List on CBOE
By Stephen Nakrosis Panbela Therapeutics, whose shares were recently delisted from the Nasdaq, said Thursday it will seek to list on the US Equity Listings Tier II Chicago Board of Options Exchange.
WSJApr 18 17:23 ET
Panbela Therapeutics, Recently Delisted From Nasdaq and Now on OTCQB, to Seek CBOE Stock Listing
Panbela Therapeutics, Recently Delisted From Nasdaq and Now on OTCQB, to Seek CBOE Stock Listing
Dow JonesApr 18 16:48 ET
Panbela Therapeutics Files for Stock and Warrant Offering
Panbela Therapeutics Files for Stock and Warrant Offering
Dow JonesApr 18 16:46 ET
No Data
No Data
Jaguar8 : I want this too. Pancreatic Cancer is one of the deadliest of all cancers. Pop passed away bec of this
TrytosaveabitOP Jaguar8: Agreed! And sorry!